Core Viewpoint - The establishment of the Jiangcheng Academy Fund aims to support the commercialization of scientific research in Wuhan, focusing on early-stage investments and fostering collaboration between academia and industry [3][4]. Group 1: Fund Overview - The Jiangcheng Academy Fund, initiated by Wuhan Jin Kong, has a target fundraising scale of 1 billion yuan and a duration of 15 years, seeking global fund managers [3]. - The fund is positioned as a cornerstone investor in scientific innovation in Wuhan, emphasizing a "government guidance, capital support, and academic leadership" operational model [3][4]. Group 2: Investment Strategy - The fund aims to create a comprehensive capital support system for academic teams, covering the entire chain from concept validation to industrialization through a combination of specialized sub-funds and direct investments [3]. - The focus is on supporting high-level laboratory results led by academicians to transition into industrial applications, particularly in key industries such as optical chips, automotive manufacturing, and healthcare [3][4]. Group 3: Academic and Industry Collaboration - Wuhan has seen a significant increase in its number of academicians, ranking fourth nationally, which is a core driver of its rise in the Nature Index for research cities [3][4]. - The fund aims to address the low conversion rates of scientific achievements in China, particularly in the medical field, where the conversion rate is below 8%, compared to 50% in the United States [4]. Group 4: Recent Activities - The "Jiangcheng Science and Technology Innovation Roadshow" featured eight innovative companies seeking a total of over 180 million yuan in funding, attracting interest from numerous investment institutions [4]. - The "Billion Hundred Enterprises Venture Capital Plan" has held nine roadshows, with 137 companies participating, resulting in 84 companies receiving a total investment of 95 million yuan [5].